Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF | PLOS ONE
![Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/cd8c5efb-f63c-42a5-b263-4e6902e1b8c6/gr2b.jpg)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology
![Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/378475b7-e33b-474e-b8c9-2d7926191eff/gr1.jpg)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology
![Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/6e8bade0-0426-4eec-a434-aa6063cacfbe/gr3.jpg)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology
![Bioinspired Cell Silicification: From Extracellular to Intracellular | Journal of the American Chemical Society Bioinspired Cell Silicification: From Extracellular to Intracellular | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.1c00814/asset/images/large/ja1c00814_0009.jpeg)
Bioinspired Cell Silicification: From Extracellular to Intracellular | Journal of the American Chemical Society
![Treatment of Heart Failure in Real‐World Clinical Practice: Findings From the REFLECT‐HF Registry in Patients With NYHA Class II Symptoms and a Reduced Ejection Fraction - Böhm - 2015 - Clinical Cardiology - Treatment of Heart Failure in Real‐World Clinical Practice: Findings From the REFLECT‐HF Registry in Patients With NYHA Class II Symptoms and a Reduced Ejection Fraction - Böhm - 2015 - Clinical Cardiology -](https://onlinelibrary.wiley.com/cms/asset/48c6683e-2970-4ea2-8244-9a6be6316b52/clc22375-fig-0001-m.jpg)
Treatment of Heart Failure in Real‐World Clinical Practice: Findings From the REFLECT‐HF Registry in Patients With NYHA Class II Symptoms and a Reduced Ejection Fraction - Böhm - 2015 - Clinical Cardiology -
Treatment of Heart Failure in Realâ•'World Clinical Practice: Findings From the <fc>REFLECTâ•'HF</fc> Regi
![Frontiers | C. elegans as an Animal Model to Study the Intersection of DNA Repair, Aging and Neurodegeneration Frontiers | C. elegans as an Animal Model to Study the Intersection of DNA Repair, Aging and Neurodegeneration](https://www.frontiersin.org/files/Articles/916118/fragi-03-916118-HTML/image_m/fragi-03-916118-g001.jpg)
Frontiers | C. elegans as an Animal Model to Study the Intersection of DNA Repair, Aging and Neurodegeneration
![Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/71350af0-e2f6-44da-9ab1-c85f69695c73/gr4.jpg)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology
Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF | PLOS ONE
Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF | PLOS ONE
Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF | PLOS ONE
![Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention - ScienceDirect Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169409X20300971-ga1.jpg)